DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 127 filers reported holding DERMIRA INC in Q3 2017. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,298,000 | -63.6% | 287,779 | +26.9% | 0.01% | -60.0% |
| Q4 2017 | $6,307,000 | -7.4% | 226,850 | -10.0% | 0.02% | -6.2% |
| Q3 2017 | $6,808,000 | -7.8% | 252,103 | -0.5% | 0.02% | -20.0% |
| Q2 2017 | $7,383,000 | +28.8% | 253,319 | +50.7% | 0.02% | +25.0% |
| Q1 2017 | $5,733,000 | – | 168,106 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
| NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
| GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
| APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
| NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
| Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
| Jeneq Management LP | 96,570 | $923,000 | 0.82% |
| Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
| PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
| Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |